💲 What are the potential price targets for CRBU set by analysts for the upcoming week?

The potential price targets for Caribou Biosciences (CRBU) set by analysts for the upcoming week are as follows:

1. **Analyst Ratings and Price Targets**: CRBU has been rated as a 'Strong Buy' by four analysts, with one analyst rating it as a 'Buy' and one as a 'Hold.' No analysts have rated it as a 'Sell.'
2. **Average Price Target**: The average price target for CRBU over the next 12 months is $5.75, which represents a significant upside potential of 194.87% from the current trading price.
3. **Price Target Range**: The price target range is quite broad, with a high forecast of $10.00 and a low forecast of $1.00. This indicates that analysts have differing opinions on the stock's potential future performance.
4. **Recent Price Target Adjustments**: There have been some significant adjustments to price targets for CRBU. For instance, Brookline Capital Markets has raised its price target to $34 from $26, representing a substantial upside potential of 1643.59%. However, Citi has lowered its price target to $6 from $30, which suggests a more cautious outlook.

In summary, analysts have set a range of potential price targets for CRBU, with the average target indicating significant upside potential. However, there are some differences in opinion among analysts, as reflected in the wide range of targets. Investors should consider these targets along with other factors such as the company's financial performance and market conditions when making investment decisions.